Business Description
Venmax Drugs & Pharmaceuticals Ltd
ISIN : INE154G01022
Compare
Compare
Traded in other countries / regions
531015.India IPO Date
1995-08-21Description
Venmax Drugs & Pharmaceuticals Ltd is engaged in the manufacturing and sale of bulk drugs. The company is engaged in the business of IT & ITES services.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.02 | |||||
| Equity-to-Asset | -2.24 | |||||
| Debt-to-Equity | -0.37 | |||||
| Debt-to-EBITDA | -1.87 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | -2.77 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year FCF Growth Rate | -80.1 | |||||
| 3-Year Book Growth Rate | 38.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.26 | |||||
| Quick Ratio | 0.26 | |||||
| Cash Ratio | 0.01 | |||||
| Days Sales Outstanding | 189.1 | |||||
| Days Payable | 337.92 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 1.14 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -9.95 | |||||
| Operating Margin % | -136 | |||||
| Net Margin % | -79.48 | |||||
| FCF Margin % | 2 | |||||
| ROA % | -93.32 | |||||
| ROIC % | -58.81 | |||||
| ROC (Joel Greenblatt) % | -434.47 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 8.05 | |||||
| Price-to-Free-Cash-Flow | 418 | |||||
| Price-to-Operating-Cash-Flow | 418 | |||||
| EV-to-EBIT | -12.96 | |||||
| EV-to-EBITDA | -13.42 | |||||
| EV-to-Revenue | 9.2 | |||||
| EV-to-FCF | 460.73 | |||||
| Earnings Yield (Greenblatt) % | -7.72 | |||||
| FCF Yield % | 0.25 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Venmax Drugs & Pharmaceuticals Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 2.753 | ||
| EPS (TTM) (₹) | -0.42 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (₹) | 0 | ||
| 20-Day SMA (₹) | 4.18 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (₹) | 4.18 - 4.18 | ||
| Shares Outstanding (Mil) | 5.24 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Venmax Drugs & Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Venmax Drugs & Pharmaceuticals Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Venmax Drugs & Pharmaceuticals Ltd Frequently Asked Questions
What is Venmax Drugs & Pharmaceuticals Ltd(BOM:531015)'s stock price today?
The current price of BOM:531015 is ₹4.18. The 52 week high of BOM:531015 is ₹4.18 and 52 week low is ₹4.18.
When is next earnings date of Venmax Drugs & Pharmaceuticals Ltd(BOM:531015)?
The next earnings date of Venmax Drugs & Pharmaceuticals Ltd(BOM:531015) is .
Does Venmax Drugs & Pharmaceuticals Ltd(BOM:531015) pay dividends? If so, how much?
Venmax Drugs & Pharmaceuticals Ltd(BOM:531015) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers